biogene

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX

HONG KONG, Nov 7, 2022 – (ACN Newswire via SEAPRWire.com) – On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. The number of Giant Biogene’s offer shares under the global offering is 22,608,800 shares at an issue price of HK$24.3... » read more

Giant Biogene has Entered Offering Stage: China’s Leading Skin Treatment Company with Annual Profits of More Than RMB800 Million

HONG KONG, Oct 26, 2022 – (ACN Newswire via SEAPRWire.com) – With the improvement of people’s consumption level and the change in consumption concept, beauty and skincare have become a daily necessity, and the beauty and health industry has ushered in a stage of rapid development. Especially in recent years, many local Chinese brands have... » read more